Professor | Min Yu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Min Yu
Contact Information	minyu@shmu.edu.cn
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Min Yu

Contact Information

minyu@shmu.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	1998/9-2002/1 PhD: Fudan University, School of Medicine, Biochemistry and Molecular Biology 1994/9-1997/7 Master's: Shanghai Medical University, Biochemistry and Molecular Biology 1979/9-1983/7 Bachelor's: East China Normal University, Chemistry
Work Experience	2007.9-Present - Fudan University, Key Laboratory of Molecular Medicine, Professor 2002/4-2007/8 - Harvard Medical School, Postdoctoral Researcher 1997/7-1998/8 - Shanghai Industrial Medical Biotechnology Co., Ltd., Deputy General Manager, Senior Engineer 1983/7-1994/8 - Taishan Medical University, Lecturer

University/Lab Affiliation and Title

Fudan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

1998/9-2002/1 PhD: Fudan University, School of Medicine, Biochemistry and Molecular Biology
1994/9-1997/7 Master's: Shanghai Medical University, Biochemistry and Molecular Biology
1979/9-1983/7 Bachelor's: East China Normal University, Chemistry

Work Experience

2007.9-Present - Fudan University, Key Laboratory of Molecular Medicine, Professor
2002/4-2007/8 - Harvard Medical School, Postdoctoral Researcher
1997/7-1998/8 - Shanghai Industrial Medical Biotechnology Co., Ltd., Deputy General Manager, Senior Engineer
1983/7-1994/8 - Taishan Medical University, Lecturer

Areas of Focus	Development of biotechnological drugs Development and application of bispecific antibodies in tumor immunotherapy Regulatory role of Brd2 in glucose and lipid metabolism
Publications	Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease, Mengfang Wu, Tian Xia, Yaran Li, Tianfa Wang, Shijia Yang, Jinchao Yu, Qiaoyan Liang, Teng Shen, Min Yu, Bing Zhao, 2022 Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy, Qingyun Yuan, Qiaoyan Liang, Zujun Sun, Xingxing Yuan, Weihua Hou, Yuxiong Wang, Huijie Wang, Min Yu, 2021 A novel oncotherapy strategy, direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non-small cell lung cancer, Bing Zhao, Mengfang Wu, Zhihuang Hu, Tianfa Wang, Jinchao Yu, Yixin Ma, Qi Wang, Yanling Zhang, Di Chen, Tianyu Li, Yaran Li, Min Yu, Huijie Wang, Wei Mo, 2021 A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer, Weihua Hou, Qingyun Yuan, Xingxing Yuan, Yuxiong Wang, Wei Mo, Huijie Wang, Min Yu, 2019 Bromodomain-containing protein 2 induces insulin resistance via the mTOR/Akt signaling pathway and an inflammatory response in adipose tissue, Ruixin Sun, Yi Wu, Weihua Hou, Zujun Sun, Yuxiong Wang, Huanhuan Wei, Wei Mo, Min Yu, 2017

Areas of Focus

Development of biotechnological drugs
Development and application of bispecific antibodies in tumor immunotherapy
Regulatory role of Brd2 in glucose and lipid metabolism

Publications

Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease, Mengfang Wu, Tian Xia, Yaran Li, Tianfa Wang, Shijia Yang, Jinchao Yu, Qiaoyan Liang, Teng Shen, Min Yu, Bing Zhao, 2022
Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy, Qingyun Yuan, Qiaoyan Liang, Zujun Sun, Xingxing Yuan, Weihua Hou, Yuxiong Wang, Huijie Wang, Min Yu, 2021
A novel oncotherapy strategy, direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non-small cell lung cancer, Bing Zhao, Mengfang Wu, Zhihuang Hu, Tianfa Wang, Jinchao Yu, Yixin Ma, Qi Wang, Yanling Zhang, Di Chen, Tianyu Li, Yaran Li, Min Yu, Huijie Wang, Wei Mo, 2021
A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer, Weihua Hou, Qingyun Yuan, Xingxing Yuan, Yuxiong Wang, Wei Mo, Huijie Wang, Min Yu, 2019
Bromodomain-containing protein 2 induces insulin resistance via the mTOR/Akt signaling pathway and an inflammatory response in adipose tissue, Ruixin Sun, Yi Wu, Weihua Hou, Zujun Sun, Yuxiong Wang, Huanhuan Wei, Wei Mo, Min Yu, 2017

Biotechnology Drug Development Bispecific Antibodies Tumor Immunotherapy Brd2 Glucose Metabolism Lipid Metabolism Cancer Treatment Insulin Resistance Molecular Biology

Cai-Ping Ren - Central South University

Zhou Jing - Zhejiang University

Linlin Wang - Zhejiang University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us